SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 22nd, 2013 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 22, 2013, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.DARA BioSciences, Inc. • October 22nd, 2013 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April___, 20141 (the “Initial Exercise Date”) and on or prior to the close of business on April__, 20192 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Mr. David J. Drutz Chief Executive Officer DARA BioSciences, Inc.DARA BioSciences, Inc. • October 22nd, 2013 • Pharmaceutical preparations • New York
